Several groups have detected EGFR gene mutations in DNA isolated from plasma [3, 12–16] or serum samples [17, 18], which serve as substitutes for tumor tissue; some groups have demonstrated a correlation between mutation status in the plasma/serum and tumor tissue [3, 12, 13, 15–18]. This evidence concerns the gene EGFR and neoplasm.